Clinical Trial Update: Boost Irradiation to the Supraclavicular Area Among High Risk cN3c Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intensified irradiation to the supraclavicular area in high-risk cN3c breast cancer patients, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Ruijin Hospital | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING